United States · FDA National Drug Code directory
Oxcarbazepine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50742-613_69d2a354-3ced-494f-bda2-f3f5c4635eaa
- Product NDC
- 50742-613
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Oxcarbazepine
- Labeler
- Ingenus Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250601
- Source listing expiry
- 20261231
Source-listed ingredients
- OXCARBAZEPINE — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50742-613-01) · 50742-613-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →